Becton, Dickinson and Company (BD) is a global medical technology company that develops, manufactures, and sells medical devices, instrument systems, and reagents. It operates through segments including BD Medical, which supplies medication delivery and diabetes care products such as syringes, needles, catheters, and infusion pumps; BD Life Sciences, offering diagnostic systems, specimen collection products, and research reagents; and BD Interventional, providing surgical, vascular, and urology devices including hernia repair and biopsy products. Customers include hospitals, clinics, laboratories, physicians, and pharmaceutical companies, with products sold in more than 190 countries. Revenue comes primarily from device and consumable sales, supplemented by instrument placements and service contracts. The United States is its largest market, though it maintains significant operations across Europe, Asia, and emerging markets.

Piotroski F-Score

Beneish M-Score

Operating Margin %

Revenue per Share

Insider Sell

Dividend Payout Ratio

PB Ratio

PE Ratio

Price

PS Ratio

Dividend Yield %

Altman Z-Score

Becton Dickinson & Co